PASADENA, Calif., Nov. 5 /PRNewswire-FirstCall/ -- For the third quarter of 2009, we reported funds from operations ("FFO") attributable to Alexandria Real Estate Equities, Inc.'s common stockholders of $50,609,000, or $1.13... [read full story]
|
RELATED
|
|
PASADENA, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Sold One Property Previously Classified as "Held For Sale" to a Life Science User Alexandria Real Estate Equities, Inc. today announced operating and financial results for the...
PASADENA, Calif., Nov. 5 /PRNewswire-FirstCall/ -- NYC(TM) Closed Follow-on Common Stock Offering with Net Proceeds of $233 Million Completed Ground-Up Development of One Property at Mission Bay, San Francisco Aggregating...
PASADENA, Calif., Nov. 5 -- Highlights Third Quarter 2009: Third Quarter 2009 Funds from Operations Per Share (Diluted) Attributable to Alexandria Real Estate Equities, Inc.'s Common Stockholders of $1.13
Investing & Markets, Finance, Banking & Insurance, Construction & Real Estate, Science Parks, Real Estate, Financial Markets, Demographics, Corporate Performance, Stock Markets, Investing, Earnings Surprises, Corporate Earnings, GlaxoSmithKline, Eli Lilly, ImClone Systems, Merck KGaA, Novartis, Hoffmann-La Roche, Johnson & Johnson, Pfizer, United States of America, California, Southern California, North America, New York, New York City, Pasadena (California)
